Phase II study of oral capecitabine in patients with advanced or metastatic pancreatic cancer

Journal of Clinical Oncology

Volumn 20, Issue 1, 2002, Pages 160-164

  Cartwright, T H ^a   Cohn, A ^a   Varkey, J A ^a   Chen, Y M ^a   Szatrowski, T P ^a   Cox, J V ^a   Schulz, J J ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE;

ADULT; ADVANCED CANCER; ANALGESIA; ANOREXIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; HUMAN; MALE; METASTASIS; NAUSEA; PAIN ASSESSMENT; PANCREAS CANCER; PHASE 2 CLINICAL TRIAL; PHYSICAL EXAMINATION; PRIORITY JOURNAL; TREATMENT OUTCOME; VOMITING; WEIGHT REDUCTION;

ADMINISTRATION, ORAL; ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; CONSUMER PRODUCT SAFETY; DEOXYCYTIDINE; FEMALE; HUMANS; MALE; NEOPLASM METASTASIS; PALLIATIVE CARE; PANCREATIC NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0036137690     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.20.1.160     Document Type: Article

References (21)

1. Cancer Statistics, 2000
2. Pain and depression in patients with newly diagnosed pancreas cancer
3. Cancer of the pancreas
4. A phase II trial of gemcitabine in patients with 5-FU refractory pancreas cancer
5. Improvement in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial
6. Tumor selective delivery of 5-fluorouracil by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenografts
7. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue
8. Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer
9. Preferential activation of capecitabine in tumor following oral administration in colorectal cancer patients
10. Pharmacology and clinical status of capecitabine
11. Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer
12. Capecitabine, an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer: Results of a randomized phase II study
13. Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: Results of a large phase III study
14. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: Results of a randomized phase III study
15. Antitumor activity of 5′-deoxy-5-fluorouridine in human digestive organ cancer xenografts and pyrimidine nucleoside phosphorylase activity in normal and neoplastic tissues from human digestive organs
16. Pharmacological study of 5′-DFUR oral administration and the clinical responses against gastrointestinal carcinoma
17. Doxifluridine as palliative treatment in advanced gastric and pancreatic cancer patients
18. STPLAN: An interactive study planning package